{
  "docId": "019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "docSlug": "6ded4b1cfe2c",
  "documentTitle": "Bristol-Myers Squibb Company (BMY)",
  "authorId": "03_Starboard_Value",
  "authorName": "Starboard Value",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2019-03-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 107,
  "pageCount": 197,
  "prevPage": 106,
  "nextPage": 108,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Uses a combination of stock price performance and revenue estimate charts to highlight management failure.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "line_chart",
    "callout_box",
    "quote_block",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6d9-fc4318e06f9b/107",
  "deckHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b#slide-107",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.18,
        "y": 0.54
      },
      "kind": "callout",
      "text": "The ozanimod RTF came less than 6 months after GED-0301 was terminated, and destroyed another $6 billion in shareholder value",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44a063e5-25b8-4028-9153-48c069bbda4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.5,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Celgene Stock Price Performance Pre- and Post-Ozanimod RTF Announcement",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38933fff-d7a2-4abd-b790-87a73a9943bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.34,
        "w": 0.38,
        "x": 0.57,
        "y": 0.41
      },
      "kind": "chart",
      "text": "Ozanimod 2027 Consensus Revenue Estimate Over Time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5cc2ec7f-1a6d-4d49-80c2-b32972ca2cc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "revenue expectations: 31%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-0f19-73dd-8e9b-0e969f14a9af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "Since the acquisition of ozanimod in July 2015, revenue expectations have already declined by 31%.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "118473ed-e5f1-4d59-ace3-1a5273518714",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.83
      },
      "kind": "paragraph",
      "text": "Latest consensus estimates for ozanimod in 2025, the year before REVLIMID goes generic, is nowhere close to peak sales estimates communicated to shareholders at the time of acquisition",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c06a8a9-96d8-4990-a3f2-8e7f8ef69062",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.38,
        "x": 0.57,
        "y": 0.22
      },
      "kind": "quote",
      "text": "We think in order for the story to get back on track that the investor community needs to gain restored trust in the management team.",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e8b8798-7142-441d-85ae-31a43b437ab9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“We think in order for the story to get back on track that the investor community needs to gain restored trust in the management team.” — Credit Suisse, February 2018",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0f19-73dd-8e9b-0879975fe406",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.04,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Source: CapitalIQ, Bloomberg, Wall Street research, press releases. (1) Consensus estimates shown for ozanimod are for 2027 as 2028 estimates were not readily available on Bloomberg.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b8bd93b-712c-461d-ac0f-89a3ff784377",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.75,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "The Initial Excitement on Ozanimod Has Already Moderated",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee9cbcab-9c3f-41d7-a982-d465286c0abc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "4d755085-8367-48e9-bd4e-07ed5bc7e877",
      "evidence": "Contrasts management's initial acquisition promises with subsequent stock price and revenue estimate declines.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}